Does Amedisys, Inc. (AMED) Have More Gas After Touching 52-Week High?

May 18, 2018 - By Julie Dion

Amedisys, Inc. (NASDAQ:AMED) Logo

Investors sentiment increased to 1.77 in Q4 2017. Its up 0.06, from 1.71 in 2017Q3. It increased, as 12 investors sold Amedisys, Inc. shares while 44 reduced holdings. 39 funds opened positions while 60 raised stakes. 31.82 million shares or 0.22% more from 31.75 million shares in 2017Q3 were reported.
California Public Employees Retirement has invested 0.01% in Amedisys, Inc. (NASDAQ:AMED). Hbk Limited Partnership holds 0.02% or 48,300 shares in its portfolio. Parkside Bankshares &, Missouri-based fund reported 17 shares. Rainier Invest Ltd has 36,110 shares for 0.8% of their portfolio. Riggs Asset Managment owns 450 shares. Great West Life Assurance Can has invested 0% in Amedisys, Inc. (NASDAQ:AMED). Intl Group Inc Inc accumulated 22,658 shares. The Hong Kong-based Point72 Asia (Hong Kong) Limited has invested 0.01% in Amedisys, Inc. (NASDAQ:AMED). Meeder Asset Management stated it has 0% in Amedisys, Inc. (NASDAQ:AMED). Prudential Fincl Inc holds 0% or 47,331 shares. The Colorado-based Pub Employees Retirement Association Of Colorado has invested 0% in Amedisys, Inc. (NASDAQ:AMED). Eaton Vance Mgmt accumulated 338,488 shares. Glenmede Na holds 0.02% or 68,600 shares in its portfolio. Moreover, Public Employees Retirement Of Ohio has 0% invested in Amedisys, Inc. (NASDAQ:AMED). Tygh Mngmt has invested 1.14% in Amedisys, Inc. (NASDAQ:AMED).

Since May 11, 2018, it had 0 insider purchases, and 2 selling transactions for $1.12 million activity. Shares for $786,708 were sold by North Michael Paul on Friday, May 11.

The stock of Amedisys, Inc. (NASDAQ:AMED) hit a new 52-week high and has $76.74 target or 3.00 % above today’s $74.51 share price. The 5 months bullish chart indicates low risk for the $2.54 billion company. The 1-year high was reported on May, 18 by Barchart.com. If the $76.74 price target is reached, the company will be worth $76.14 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock increased 0.11% or $0.085 during the last trading session, reaching $74.505. About 45,588 shares traded. Amedisys, Inc. (NASDAQ:AMED) has risen 18.43% since May 18, 2017 and is uptrending. It has outperformed by 6.88% the S&P500.

Analysts await Amedisys, Inc. (NASDAQ:AMED) to report earnings on July, 25. They expect $0.78 EPS, up 25.81 % or $0.16 from last year’s $0.62 per share. AMED’s profit will be $26.57M for 23.88 P/E if the $0.78 EPS becomes a reality. After $0.79 actual EPS reported by Amedisys, Inc. for the previous quarter, Wall Street now forecasts -1.27 % negative EPS growth.

Amedisys, Inc. (NASDAQ:AMED) Ratings Coverage

Among 6 analysts covering Amedisys (NASDAQ:AMED), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Amedisys has $8000 highest and $66.0 lowest target. $71.25’s average target is -4.37% below currents $74.505 stock price. Amedisys had 7 analyst reports since January 23, 2018 according to SRatingsIntel. On Tuesday, April 17 the stock rating was maintained by SunTrust with “Buy”. RBC Capital Markets upgraded Amedisys, Inc. (NASDAQ:AMED) on Monday, March 19 to “Outperform” rating. William Blair maintained the shares of AMED in report on Tuesday, January 23 with “Buy” rating. The stock has “Buy” rating by Jefferies on Wednesday, February 28. Robert W. Baird maintained the stock with “Hold” rating in Thursday, March 1 report. The firm has “Buy” rating given on Thursday, March 29 by Oppenheimer. On Tuesday, May 8 the stock rating was maintained by Robert W. Baird with “Neutral”.

More notable recent Amedisys, Inc. (NASDAQ:AMED) news were published by: Globenewswire.com which released: “Amedisys Celebrates More Than 5700 Nurses During National Nurses Week” on May 07, 2018, also Nasdaq.com with their article: “Amedisys to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference” published on May 14, 2018, Globenewswire.com published: “Amedisys Closes on Acquisition Expanding Personal Care to Tennessee” on May 02, 2018. More interesting news about Amedisys, Inc. (NASDAQ:AMED) were released by: Seekingalpha.com and their article: “Amedisys’ (AMED) CEO Paul Kusserow on Q1 2018 Results – Earnings Call Transcript” published on May 13, 2018 as well as Globenewswire.com‘s news article titled: “Amedisys Welcomes Sharon Brunecz as Chief Human Resources Officer” with publication date: April 24, 2018.

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. The company has market cap of $2.54 billion. It operates through three divisions: Home Health, Hospice, and Personal Care. It has a 84.66 P/E ratio. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, and aides for its patients to complete their important personal tasks.

Amedisys, Inc. (NASDAQ:AMED) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.